Galectin‐3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care
出版年份 2022 全文链接
标题
Galectin‐3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care
作者
关键词
-
出版物
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 112, Issue 5, Pages 1041-1052
出版商
Wiley
发表日期
2022-09-20
DOI
10.1002/jlb.5mr0822-673r
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
- (2021) Marina Stasenko et al. Scientific Reports
- Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3
- (2021) Viktoria Heine et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
- (2021) Jooeun Bae et al. LEUKEMIA
- Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells
- (2020) Shigemi Sasawatari et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
- (2020) Akira Hara et al. Biomolecules
- Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression
- (2020) Lei Wang et al. BIOCHEMICAL PHARMACOLOGY
- The promise of Immuno-oncology: implications for defining the value of cancer treatment
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature
- (2019) Ioannis Boutas et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Role and regulation mechanism of Gal-3 in non-small cell lung cancer and its potential clinical therapeutic significance
- (2019) Xiao-Ning Jiang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Roles of galectin-3 in metabolic disorders and tumor cell metabolism
- (2019) Ying-Shuang Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis
- (2019) Chengyan Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1
- (2019) Zilong Li et al. Frontiers in Cell and Developmental Biology
- Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
- (2018) Salvatore Sciacchitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- The Role of Galectins in Cervical Cancer Biology and Progression
- (2018) Lufang Wang et al. Biomed Research International
- Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics
- (2018) Karrington McLeod et al. Journal of Cell Communication and Signaling
- The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
- (2018) Mohammad Farhad et al. OncoImmunology
- Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
- (2017) Monica Gordon-Alonso et al. Nature Communications
- Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
- (2017) Sofia Nascimento dos Santos et al. Oncotarget
- The extracellular matrix in breast cancer
- (2016) Jacob Insua-Rodríguez et al. ADVANCED DRUG DELIVERY REVIEWS
- Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans
- (2016) Melanie L. Talaga et al. BIOCHEMISTRY
- Galectin 3 as a guardian of the tumor microenvironment
- (2016) Peter P. Ruvolo BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression
- (2016) Lei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
- (2016) Susanna Mandruzzato et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1
- (2016) Celeste C. Goh et al. JOURNAL OF IMMUNOLOGY
- Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
- (2016) Andrée-Anne Grosset et al. Oncotarget
- Pectic-Oligoshaccharides from Apples Induce Apoptosis and Cell Cycle Arrest in MDA-MB-231 Cells, a Model of Human Breast Cancer
- (2015) Ladan Delphi et al. Asian Pacific Journal of Cancer Prevention
- Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults
- (2015) E. I. Schindler et al. CLINICAL CHEMISTRY
- Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production
- (2015) Maryam Salimi et al. JOURNAL OF IMMUNOLOGY
- Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
- (2015) Chandan Verma et al. Journal of Translational Medicine
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Higher Incidence of Aggressive Breast Cancers in African-American Women: A Review
- (2015) Gloria J. Morris et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
- (2015) Joana T. de Oliveira et al. PLoS One
- Galectin-3 in cancer
- (2014) Lin Song et al. CLINICA CHIMICA ACTA
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Galectin-3 in Leukocyte Recruitment in a Murine Model of Lung Infection by Streptococcus pneumoniae
- (2014) J. Nieminen et al. JOURNAL OF IMMUNOLOGY
- Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion
- (2014) S. R. Stowell et al. JOURNAL OF IMMUNOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice
- (2014) Tian Wang et al. MOLECULAR BIOLOGY REPORTS
- Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
- (2014) Hao Zhang et al. PLoS One
- Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
- (2014) Rafael Yamashita Ikemori et al. PLoS One
- Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
- (2014) Monica Gordon-Alonso et al. OncoImmunology
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
- (2013) Weizhen Jia et al. AMERICAN JOURNAL OF PATHOLOGY
- Myeloid-derived suppressor cells in breast cancer
- (2013) Joseph Markowitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Galectin-3– and phospho-caveolin-1–dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells
- (2013) Cecile Boscher et al. MOLECULAR BIOLOGY OF THE CELL
- Abstract 2017: Galectin-3 SNP rs10148371 in the anti-death motif NWGR is related to the colon cancer incidence in African Americans
- (2012) Pratima Nangia-Makker et al. CANCER RESEARCH
- Galectin-3 Protein Regulates Mobility of N-cadherin and GM1 Ganglioside at Cell-Cell Junctions of Mammary Carcinoma Cells
- (2012) Cécile Boscher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations inN- andO-Glycosylation
- (2012) Aristotelis Antonopoulos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galectin-3 in preneoplastic lesions of glioma
- (2012) Nguyen Huy Binh et al. JOURNAL OF NEURO-ONCOLOGY
- Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer
- (2012) Sayaka Yamaki et al. SURGERY TODAY
- Breast cancer subtypes express distinct receptor repertoires for tumor-associated macrophage derived cytokines
- (2011) Kelly S. Levano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
- (2011) H. Barrow et al. CLINICAL CANCER RESEARCH
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
- (2011) Yili Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Galectin-3 Enhances Proliferation and Angiogenesis of Endothelial Cells Differentiated from Bone Marrow Mesenchymal Stem Cells
- (2011) S.Y. Wan et al. TRANSPLANTATION PROCEEDINGS
- Diagnostic Utility of Galectin-3 in Thyroid Cancer
- (2010) Connie G. Chiu et al. AMERICAN JOURNAL OF PATHOLOGY
- Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis
- (2010) Huamei Forsman et al. ARTHRITIS AND RHEUMATISM
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
- (2010) Ja Seung Koo et al. YONSEI MEDICAL JOURNAL
- Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways
- (2009) Andrew Filer et al. ARTHRITIS AND RHEUMATISM
- Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
- (2009) Dezheng Huo et al. JOURNAL OF CLINICAL ONCOLOGY
- A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death
- (2009) N. G. Than et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
- (2009) H.-Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
- (2008) V. Balan et al. CANCER RESEARCH
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
- (2008) Vladislav V. Glinsky et al. CARBOHYDRATE RESEARCH
- Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes
- (2008) Nathalie Demotte et al. IMMUNITY
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now